Search

Displaying results 7501 - 7510 of 8517 in total

Drug
Flezurafenib
go.drugbank.com/drugs/DB21725
Experimental
Flezurafenib has a monoisotopic molecular weight of 456.16 Da.
Drug
Bavituximab
go.drugbank.com/drugs/DB05136
Investigational
Bavituximab is a chimeric Anti-PS monoclonal antibody analog which is used to potentially treat cancers and viral infections. It binds to phosphatidylserine and other exposed host cell lipids when induced by cellular stress. Additional a...
Drug
Viralym-C
go.drugbank.com/drugs/DB17975
Investigational
It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection.[A260291, L47241]
Drug
Zibrofusidic acid
go.drugbank.com/drugs/DB20799
Investigational
Zibrofusidic acid has a monoisotopic molecular weight of 594.26 Da.
Drug
CCR5 mAb
go.drugbank.com/drugs/DB05906
Experimental
It was generated by HGS using the Abgenix XenoMouse technology.
Drug
YKP-1358
go.drugbank.com/drugs/DB06109
Experimental
YKP1358 is a novel serotonin (5-HT2A) and dopamine (D2) antagonist that has demonstrated potent activity in animals that relates to both positive and negative symptoms of schizophrenia.
Drug
Evixapodlin
go.drugbank.com/drugs/DB21520
Investigational
Evixapodlin has a monoisotopic molecular weight of 690.22 Da.
Drug
Phenylmercuric acetate
go.drugbank.com/drugs/DB17044
Experimental
Phenylmercuric acetate is an organomercurial compound used as a fungicide and slimicide.[A253082]
Drug
Chelerythrine
go.drugbank.com/drugs/DB17024
Experimental
A benzophenanthridine alkaloid evaluated as a kinase-inhibitor.[A252982]
Drug
CYNK-001
go.drugbank.com/drugs/DB15722
Investigational
CYNK-001 is a novel allogenic off-the-shelf natural killer (NK) cell therapy originating from human placental CD34+ hematopoietic stem cells and enriched with CD56+/CD3-.